COMMUNIQUÉS West-GlobeNewswire

King Faisal Specialist Hospital & Research Centre Holds Firm as Global and Regional Healthcare Leader
15/02/2024
RIYADH, Saudi Arabia, Feb. 15, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH&RC) has once again secured its position for the second consecutive year as a global leader in [...]
Notice to Convene the Annual General Meeting of Genmab A/S
15/02/2024
Company Announcement Genmab A/S to hold Annual General Meeting on Wednesday March 13, 2024 COPENHAGEN, Denmark; February 15, 2024 – Genmab A/S (Nasdaq: GMAB) summons the Annual General Meeting on Wednesday, March 13, [...]
RadNet and JVS SoCal Create ImagingWorks®, an Innovative Partnership to Launch Career Training Programs for Medical Imaging
15/02/2024
LOS ANGELES, Feb. 15, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announces the formation of a new [...]
Ipsen S.A. publishes its 2023 Consolidated Financial Statements
15/02/2024
Ipsen S.A. - 2023 Consolidated Financial Statements Attachment Ipsen - 2023 Consolidated Financial Statements
Ipsen S.A. publie ses comptes consolidés 2023
15/02/2024
Ipsen S.A. - Etats financiers consolidés 2023 Pièce jointe Ipsen - Comptes consolidés 2023
JOHNSON & JOHNSON MEDTECH LAUNCHES NEW PRESBYOPIA-CORRECTING INTRAOCULAR LENS TECNIS PURESEE IN EMEA
15/02/2024
Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision LIMERICK, IRELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Johnson & Johnson MedTech*, a global leader in eye health, [...]
Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
15/02/2024
LONDON and RALEIGH, N.C., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the fourth quarter and full year [...]
Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 Guidance
15/02/2024
Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 Guidance Total revenues of €153.7 million, including product sales of €144.6 million Product sales surpassed pre-pandemic (2019) sales by 12% and 2022 [...]
Valneva publie son chiffre d’affaires et sa trésorerie pour l’exercice 2023 et fournit des indications préliminaires pour l’exercice 2024
15/02/2024
Valneva publie son chiffre d’affaires et sa trésorerie pour l’exercice 2023 et fournit des indications préliminaires pour l’exercice 2024 Chiffre d’affaires total de 153,7 millions d’euros dont 144,6 millions d’euros de [...]
Fagron delivers strong performance with 12% topline growth and 14% increase in REBITDA for FY 2023
15/02/2024
Regulated information – inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 15 February 2024 – 7AM CET Fagron delivers strong performance with 12% topline growth and 14% increase in REBITDA for FY 2023 [...]
CARBIOS and De Smet Engineers & Contractors enter engineering partnership for construction of world’s first PET biorecycling plant
15/02/2024
CARBIOS and De Smet Engineers & Contractors enter engineering partnership for construction of world’s first PET biorecycling plant Clermont-Ferrand, France, 15 February 2024 (06.45am CET) CARBIOS (Euronext Growth [...]
CARBIOS et De Smet Engineers & Contractors signent un partenariat d'ingénierie pour la construction de la première usine de biorecyclage de PET au monde
15/02/2024
CARBIOS et De Smet Engineers & Contractors signent un partenariat d'ingénierie pour la construction de la première usine de biorecyclage de PET au monde Clermont-Ferrand, France, 15 February 2024 (06.45am CET) [...]
Prime Medicine Announces Pricing of Upsized Public Offering
15/02/2024
CAMBRIDGE, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced [...]
United States Food & Drug Administration (FDA) Grants Mesoblast Orphan-Drug Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease
15/02/2024
NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the United States Food and Drug [...]
Lowell Farms Inc. Appoints Jamie Schniedwind as Chief Financial Officer
15/02/2024
SALINAS, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California-born cannabis company with advanced production capabilities including extraction, [...]
Quipt Home Medical Reports Strong Operating Performance With Record First Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 60% and Adjusted EBITDA Growth of 71%
14/02/2024
Posts Adjusted EBITDA Margin of 23.5% and 2% Sequential Organic Growth CINCINNATI, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “ Company ”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical [...]
ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit
14/02/2024
SOUTH SAN FRANCISCO and SAN DIEGO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic [...]
NurExone Launches Licensing Efforts for ExoTherapy Platform
14/02/2024
Huge opportunity for development of nanodrugs for wide variety of clinical indications TORONTO and HAIFA, Israel, Feb. 14, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “ [...]
Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference
14/02/2024
- Presentations will Highlight Initial Data Announced in January 2024 Demonstrating Proof-of-Concept in its DM1 and DMD Programs, Validating the Promise of the FORCE™ Platform and Targeted Delivery to Muscle - - [...]

Pages